Filing Flows › SkinHealth Systems (SKIN) › Capital expenditures
SkinHealth Systems (SKIN) capital expenditures by quarter
SkinHealth Systems' capital expenditures were $93K in Q3 2026 (third quarter 2026), -78% from Q2 2026. Over the last 6 quarters it ranged from $27K (Q3 2025) to $427K (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $93K | -78% | +244% |
| Q2 2026 | $427K | +207% | +364% |
| Q4 2025 | $139K | +415% | — |
| Q3 2025 | $27K | -71% | — |
| Q2 2025 | $92K | +104% | — |
| Q1 2025 | $45K | — | — |
Q3 2026 at a glance
SkinHealth Systems, Q3 2026: revenue $69.2M (-2% year over year), operating margin 7.2%, net loss $888K, operating cash flow $11.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is SkinHealth Systems' capital expenditures?
SkinHealth Systems' capital expenditures were $93K in Q3 2026 (third quarter 2026), -78% from Q2 2026.
How has SkinHealth Systems' capital expenditures changed?
Over the last 6 quarters it ranged from $27K (Q3 2025) to $427K (Q2 2026).